GrowthWorks Capital
131
10M
85
4.09
12
0.35
40
- Stages of investment
- Areas of investment
Summary
In 1992 was created GrowthWorks Capital, which is appeared as VC. The main office of represented VC is situated in the Vancouver. The fund was located in North America if to be more exact in Canada.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Celator Pharmaceuticals, OneChip Photonics, CELLFOR. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. We can highlight the next thriving fund investment areas, such as Manufacturing, Health Care.
The current fund was established by David Levi. Besides them, we counted 2 critical employees of this fund in our database.
The important activity for fund was in 2006. The fund is constantly included in 2-6 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2009. Considering the real fund results, this VC is 4 percentage points less often commits exit comparing to other organizations. Opposing the other organizations, this GrowthWorks Capital works on 3 percentage points more the average amount of lead investments.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the GrowthWorks Capital, startups are often financed by Business Development Bank of Canada, Ventures West, VenGrowth Asset Management. The meaningful sponsors for the fund in investment in the same round are VenGrowth Asset Management, OVP Venture Partners, Canadian Medical Discoveries Fund. In the next rounds fund is usually obtained by Yaletown Partners, Business Development Bank of Canada, Ventures West.
Investments analytics
Analytics
- Total investments
- 131
- Lead investments
- 12
- Exits
- 40
- Rounds per year
- 4.09
- Follow on index
- 0.35
- Investments by industry
- Software (49)
- Biotechnology (35)
- Health Care (22)
- Enterprise Software (17)
- Information Technology (14) Show 113 more
- Investments by region
-
- Canada (105)
- United States (22)
- United Kingdom (2)
- Japan (1)
- Denmark (1)
- Peak activity year
- 2007
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 29M
- Group Appearance index
- 0.80
- Avg. company exit year
- 10
- Avg. multiplicator
- 1.82
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Aegera Therapeutics | 20 Nov 2006 | Biotechnology, Health Care, Pharmaceutical | Late Stage Venture | 11M | Quebec, Montreal, Canada |
RushBit 瑞兔 | 15 Dec 2018 | E-Commerce, Software, Financial Services | Seed | 63K | Taipei, Taiwan |
Spotta | 15 Dec 2023 | Hospitality, Housekeeping Service | Early Stage Venture | 4M | England, Cambridge, United Kingdom |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.